Grenada vs Sint Maarten (Dutch part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Grenada
0.2%
in 2024
Sint Maarten (Dutch part)
0.2%
in 2024
Grenada rank
78th
Sint Maarten (Dutch part) rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Grenada
- Sint Maarten (Dutch part)
How they compare
Grenada currently reports 0.2% against 0.2% in Sint Maarten (Dutch part), a difference of 0.0%.
Across all 10 years both countries report, Sint Maarten (Dutch part) has been ahead every year.
Grenada ranks 78th and Sint Maarten (Dutch part) ranks 78th of 215 countries.
Head to head by decade
| Decade | Grenada | Sint Maarten (Dutch part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Grenada or Sint Maarten (Dutch part)?
- Grenada, at 0.2% against 0.2% in Sint Maarten (Dutch part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Grenada and Sint Maarten (Dutch part)?
- 0.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and Sint Maarten (Dutch part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Grenada and Sint Maarten (Dutch part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Grenada ranks 78th and Sint Maarten (Dutch part) ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.